Search Orphan Drug Designations and Approvals
-
| Generic Name: | (R)-5-({4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl}methyl)-(5-2H)-1,3-thiazolidine-2,4-dione hydrochloride |
|---|---|
| Date Designated: | 04/11/2022 |
| Orphan Designation: | Treatment of X-Linked Adrenoleukodystrophy |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Poxel S.A. 259/261 Avenue Jean Jaures Lyon F-69007 France The sponsor address listed is the last reported by the sponsor to OOPD. |
-
